Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Aug 9, 2012 · 10-Q · 40 days after period end · 0001193125-12-346661
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Net Income | -$4.57M | -$1.93M | -$3.58M |
| EPS Diluted | -$0.46 | -$0.05 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 9, 2012 · 40 d after period end
